Grace Therapeutics, Inc. · NASDAQ:GRCE

Nantahala Capital Management, LLC reported a 9.99% stake in Grace Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed May 15, 2025

Nantahala Capital Management, LLC reported a 9.99% stake in Grace Therapeutics, Inc., 1,391,773 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).

Stake
9.99%
Shares
1,391,773
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC9.99%1,391,773
Wilmot B. Harkey9.99%1,391,773
Daniel Mack9.99%1,391,773

Source

View original at SEC

Related